<i>IDH</i> mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy

Bibliographic Details
Main Authors:	Rami Komrokji, Najla al Ali, Onyee Chan, Kendra Sweet, Andrew Kuykendall, Jeffrey Lancet, Eric Padron, David A. Sallman
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2022-11-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/10880

Internet